最終更新日：2025/11/28
In recent clinical trials, sapacitabine showed promising activity as an oral nucleoside analogue prodrug for treating certain leukemias.
正解を見る
In recent clinical trials, sapacitabine showed promising activity as an oral nucleoside analogue prodrug for treating certain leukemias.
音声機能が動作しない場合はこちらをご確認ください
編集履歴（0）
